We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,040.00
Bid: 12,040.00
Ask: 12,042.00
Change: -116.00 (-0.95%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks higher as focus shifts towards Greece

Thu, 19th Mar 2015 17:30

UK equities registered slight gains as traders digested the policy announcement issued by the US Federal Reserve overnight and despite the renewed tensions evident in Greek funding markets.The Footsie ended the day 17 points higher at 6,962.32, with some effects from Wednesday's Budget from Chancellor George Osborne also still filtering through.As expected, the US central bank yesterday omitted any reference to being "patient" when starting to tighten interest rates, but the 17 members of the Federal Open Market Committee nearly halved their median projection for the level of the Fed funds rate at year-end 2015 to 0.625%.Investors were increasingly focusing on Thursday's summit of European Union heads of government and the news-flow surrounding the negotiations with Greece.The yield on the benchmark 10-year Greek government bond sprinted 104 basis points higher to 12.14%.That was despite reports earlier in the day that the European Central Bank had opposed forbidding Greek lenders from purchasing short-term government securities.Some market reports cited sources according to whom the daily outflows of Greek deposits had reached one-month highs.Against analysts' predictions Norway's central bank maintained its deposit rate at 1.25%, instead of reducing it by 25 basis points. Nonetheless, the monetary authority clearly signalled that it will soon be lowering its key rate further, analysts at Capital Economics said.Earlier in the day Switzerland's central bank, the SNB, kept its target range for the three-month Libor unchanged, at between -1.25% and -0.25%, as expected. However, the SNB cautioned that it could cut rates further or intervene in foreign exchange markets, if necessary, to curb strength in the swiss franc's value.Next drops after full-year profits UK clothing retailerNext grew its underlying pre-tax profit by 12.5% last year as overall sales rose by 7.2%. The company said its share buyback scheme meant that underlying EPS grew by 14.7% and dividends for the full year will increase by 16.3%, to 150p.Auto Trader Group, the UK car classified ad company on Thursday priced 590m shares at 235p/share in its initial public offering in the London market. The company is raising £437m of net proceeds in the offer with its private equity owner, Apax expected to raise around £926.2m out of the flotation. As of 12:18 the shares were changing hands at 268.75p.Chip designer ARM Holdings's market share in servers may reach 20% by 2020, versus less than 1% at present, the company has reportedly said. The London-listed outfit was scheduled to make a presentation at today's Bank of America Merrill Lynch Technology & Beyond Conference, in Taiwan.Electronics components distributor Premier Farnell reported adjusted profits before tax down 3% to reach £74m in 2014 but maintained its full-year dividend pay-out at 10.4p. That came on the back of a 0.8% fall in full-year revenues to £960.1m. However, the company's operating margins declined by less than forecast by analysts, slipping by 40 basis points, to 9.2%. The analyst consensus was for margins of 9%. Earnings per share (EPS) on an adjusted basis came in at 13.8p, down 3.5% from the prior year but ahead of the 13.5p which analysts had pencilled in.AstraZeneca has signed an agreement with Japanese-headquartered company Daiichi Sankyo to jointly commercialise a new drug called Movantik, an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. No longer labelled a controlled substance by the US Drug Enforcement Administration, its launch has been scheduled to take place early in April 2015.Savills reported a 21% increase in pre-tax profit to £84.7m, as revenue rose 19% to £1.08bn driven by a 38% increase in transaction advisory revenue, which the company attributed to the performance of the Savills Studley business in the US, strong performances in Asia and the UK and recovery in some European markets.Market MoverstechMARK 3,254.47 +0.15%FTSE 100 6,962.32 +0.25%FTSE 250 17,438.15 +0.43%FTSE 100 - RisersFresnillo (FRES) 679.00p +5.43%Randgold Resources Ltd. (RRS) 4,826.00p +3.23%Marks & Spencer Group (MKS) 531.50p +3.10%Tullow Oil (TLW) 309.60p +2.25%Antofagasta (ANTO) 695.00p +1.98%Aviva (AV.) 566.00p +1.89%BHP Billiton (BLT) 1,485.50p +1.89%Kingfisher (KGF) 374.40p +1.88%Friends Life Group Limited (FLG) 432.10p +1.86%GKN (GKN) 375.10p +1.74%FTSE 100 - FallersNext (NXT) 7,315.00p -4.00%British American Tobacco (BATS) 3,668.00p -3.37%TUI AG Reg Shs (DI) (TUI) 1,181.00p -2.24%Anglo American (AAL) 1,046.00p -2.20%Meggitt (MGGT) 577.50p -1.70%Imperial Tobacco Group (IMT) 3,155.00p -1.44%Hargreaves Lansdown (HL.) 1,189.00p -1.41%Admiral Group (ADM) 1,518.00p -1.24%St James's Place (STJ) 966.50p -1.18%CRH (CRH) 1,751.00p -1.13%FTSE 250 - RisersSoco International (SIA) 160.10p +8.25%Premier Oil (PMO) 146.70p +8.03%Indivior (INDV) 201.90p +5.98%Acacia Mining (ACA) 248.00p +5.58%Afren (AFR) 3.31p +5.28%Supergroup (SGP) 918.50p +5.15%Renishaw (RSW) 2,588.00p +4.65%Centamin (DI) (CEY) 53.70p +4.07%Evraz (EVR) 195.20p +3.77%Crest Nicholson Holdings (CRST) 441.00p +3.72%FTSE 250 - FallersBrit (BRIT) 278.50p -8.60%Lancashire Holdings Limited (LRE) 632.50p -6.92%Hiscox Ltd (CDI) (HSX) 805.00p -5.07%Jupiter Fund Management (JUP) 412.80p -3.12%Jimmy Choo (CHOO) 170.00p -2.86%Ted Baker (TED) 2,746.00p -2.52%Serco Group (SRP) 170.60p -2.29%FirstGroup (FGP) 92.95p -2.05%Ladbrokes (LAD) 111.20p -2.03%Jardine Lloyd Thompson Group (JLT) 1,049.00p -1.96%
More News
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.